Unknown not molecularly defined

The designation 'Unknown not molecularly defined' is a placeholder used in pharmacological databases, such as ChEMBL, to categorize drugs or experimental compounds whose specific molecular targets (e.g., receptors, enzymes, or transporters) have not been identified (Gaulton et al., 2012). This classification is often applied to agents discovered through phenotypic screening, where a biological effect is observed in a cell or organism without prior knowledge of the molecular initiator (Moffat et al., 2017). Because this entry does not refer to a specific protein or genetic entity, it does not possess standard biological functions or molecular classifications. In many cases, these compounds are legacy drugs or natural products with complex or polypharmacological profiles that complicate target identification. As research techniques like chemical proteomics and CRISPR-based screening improve, many such 'unknown' targets are eventually characterized and reassigned to specific molecular entities. Consequently, this term represents a lack of data rather than a distinct biological target.

Other names

UnknownNot molecularly definedUnspecified targetUnknown not molecularly defined)

The mechanism of action is unknown or has not been molecularly characterized.